Yiling Pharmaceutical (002603.SZ): The application for clinical trials of the innovative drug "G201-Na capsules" has been approved.

Translated to Smart Finance APP News, according to the announcement released by LINGYUE Pharmaceutical (002603.SZ), the company received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration on July 7, 2025, involving the drug: "G201-Na Capsule".